Maternal Anti-Ro Antibody Titers Obtained With Commercially Available Immunoassays Are Strongly Associated With Immune-Mediated Fetal Heart Disease.

Saved in:
Bibliographic Details
Title: Maternal Anti-Ro Antibody Titers Obtained With Commercially Available Immunoassays Are Strongly Associated With Immune-Mediated Fetal Heart Disease.
Authors: Jaeggi E; Labatt Family Heart Centre, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Kulasingam V; Division of Clinical Biochemistry, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada., Chen J; Department of Laboratory Medicine & Pathobiology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Fan CS; Rogers Computational Program, Ted Rogers Centre for Heart Research, University Health Network, Toronto, Ontario, Canada., Laskin C; Department of Medicine, Mount Sinai Hospital, New York, New York., Hamilton RM; Labatt Family Heart Centre, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Hiraki LT; Division of Rheumatology, The Hospital for Sick Children, University of Toronto, Toronto, Canada., Silverman ED; Division of Rheumatology, The Hospital for Sick Children, University of Toronto, Toronto, Canada., Sepiashvili L; Department of Laboratory Medicine & Pathobiology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2023 Sep; Vol. 75 (9), pp. 1556-1565. Date of Electronic Publication: 2023 Jun 11.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-5205 (Electronic) Linking ISSN: 23265191 NLM ISO Abbreviation: Arthritis Rheumatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2326-5205
DOI:10.1002/art.42513